MINI FUTURE LONG - MEDTRONIC Share Price

Certificat

DE000BP8Q2J1

Market Closed - Boerse Frankfurt Warrants 20:50:30 03/05/2024 BST
4.54 EUR +1.57% Intraday chart for MINI FUTURE LONG - MEDTRONIC
Current month+2.24%
1 month-5.98%
Date Price Change Volume
03/05/24 4.56 +2.01% 0
02/05/24 4.47 +0.22% 0
30/04/24 4.46 -0.22% 0
29/04/24 4.47 +1.82% 0
26/04/24 4.39 +1.62% 0

Real-time Boerse Frankfurt Warrants

Last update May 03, 2024 at 08:50 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN BP8Q2J
ISINDE000BP8Q2J1
Date issued 25/04/2013
Strike 32.85 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.57
Lowest since issue 0.86

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.69 USD
Average target price
94.77 USD
Spread / Average Target
+16.02%
Consensus